✦ LIBER ✦

Single-dose zoledronic acid leads the race in Paget's disease

Book ID: 120852662
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2005
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200515040-00030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single IV zoledronic acid infusion vs 60

Single IV zoledronic acid infusion vs 60 days of oral risedronic acid in Paget's disease

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Single infusion of zoledronate in Paget’

Single infusion of zoledronate in Paget’s disease of bone: a placebo-controlled, dose-ranging study

✍ H Buckler; W Fraser; D Hosking; W Ryan; M.J Maricic; F Singer; M Davie; I Fogelm 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Comparison of a Single Infusion of Zoled

Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget's Disease

✍ Reid, Ian R.; Miller, Paul; Lyles, Kenneth; Fraser, William; Brown, Jacques P.; 📂 Article 📅 2005 🏛 Massachusetts Medical Society 🌐 English ⚖ 155 KB

The use of zoledronic acid for paget’s d

The use of zoledronic acid for paget’s disease of bone

✍ Michael Maricic 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 103 KB

Long-term efficacy of zoledronic acid co

Long-term efficacy of zoledronic acid compared with risedronate in Paget's disease

✍ I. Reid⁎; K.W. Lyles; G. Su; J. Brown; J. Walsh; J. del Pino; P. Miller; W.D. Fr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A single infusion of zoledronic acid pro

A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years

✍ Ian R Reid; Kenneth Lyles; Guoqin Su; Jacques P Brown; John P Walsh; Javier del 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 885 KB

## Abstract Two trials have shown that a single 5‐mg infusion of zoledronic acid achieves much higher response rates in Paget disease of bone than risedronate. The duration of this effect is unknown. We have conducted an open follow‐up of responders from the two trials (152 originally treated with